Approval · Notice of Compliance 34506 · 2024
DONEPEZIL: Notice of Compliance 34506
Issued December 5, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34506
- Date
- December 5, 2024
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement between two manufacturers
- Canadian reference product
- ARICEPT (Pfizer Canada Ulc)
Products in this notice
Medicinal ingredients
- DONEPEZIL HYDROCHLORIDE 5 MG per TAB
- DONEPEZIL HYDROCHLORIDE 10 MG per TAB